Sandbox:Mitra3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}} | ||
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 | |B01=Reperfusion|B02=Maintenance of RV preload|B03=Decreased RV afterload|B04=Restoring Rate/Rhythm and AV synchrony|B05=Inotropic support|B06=Mechanical Circulatory Support}} | {{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 | |B01=Reperfusion|B02=Maintenance of RV preload|B03=Decreased RV afterload|B04=Restoring Rate/Rhythm and AV synchrony|B05=Inotropic support|B06=Mechanical Circulatory Support}} | ||
{{familytree | | | |!| | | |!| | | | |!| | | |!| | | |!| | | | |!| | |}} | {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | |}} | ||
{{familytree |boxstyle=text-align: left; | | | C01 | | C02 | | | |C03| | | |C04| | | |C05| | | |C06| | C01=• Thrmobolysis<br>• Percutaneous coronary intervention<be> | {{familytree |boxstyle=text-align: left; | | | C01 | | C02 | | | |C03| | | |C04| | | |C05| | | |C06| | C01=• Thrmobolysis<br>• Percutaneous coronary intervention<be> | ||
|C02= • Avoidance of preload reducing agents, such as:<br> | |C02= • Avoidance of preload reducing agents, such as:<br> | ||
Revision as of 17:46, 3 August 2020
| Therapuetic Considerations in RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reperfusion | Maintenance of RV preload | Decreased RV afterload | Restoring Rate/Rhythm and AV synchrony | Inotropic support | Mechanical Circulatory Support | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Thrmobolysis • Percutaneous coronary intervention<be> | • Avoidance of preload reducing agents, such as:
| • Systemic or pulmonary vasodilators: *Inhaled nitric oxide | • In patients with bradyarrhthmias: Atropine Pacemaker | In patients with refractory hypotension | May be needed in patients with cardiogenic shock secondary to RVMI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||